home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Corbus Pharmaceuticals Holdings, Inc. - Common Stock (NQ:CRBP)

7.830 +0.440 (+5.95%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Corbus Pharmaceuticals Holdings, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Cannabis Stock Gainers And Losers From January 31, 2022 ↗

January 31, 2022

GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76

Via Benzinga

The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January ↗

January 30, 2022

This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.

Via Talk Markets

Cannabis Stock Gainers And Losers From January 27, 2022 ↗

January 27, 2022

GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03

Via Benzinga

Cannabis Stock Gainers And Losers From January 26, 2022 ↗

January 26, 2022

GAINERS: Item 9 Labs (OTC:

Via Benzinga

Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD ↗

January 23, 2022

This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a...

Via Talk Markets

Cannabis Stock Gainers And Losers From January 21, 2022 ↗

January 21, 2022

GAINERS: Item 9 Labs (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 18, 2022 ↗

January 18, 2022

GAINERS: Item 9 Labs (OTC:

Via Benzinga

Marijuana & Psychedelic Drug Stocks Continue To Decline ↗

January 16, 2022

The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are...

Via Talk Markets

Cannabis Stock Gainers And Losers From January 14, 2022 ↗

January 14, 2022

GAINERS: Cannabix Technologies (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 13, 2022 ↗

January 13, 2022

GAINERS: MGC Pharmaceuticals (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 12, 2022 ↗

January 12, 2022

GAINERS: Cannabix Technologies (OTC:

Via Benzinga

JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th

January 12, 2022

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ /...

From JTC Team, LLC

Via AccessWire

Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High ↗

January 09, 2022

There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents.

Via Talk Markets

Cannabis Stock Gainers And Losers From January 7, 2022 ↗

January 07, 2022

GAINERS: Cannabix Technologies (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 6, 2022 ↗

January 06, 2022

GAINERS: Cannabix Technologies (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 5, 2022 ↗

January 05, 2022

GAINERS: Rhinomed (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 4, 2022 ↗

January 04, 2022

GAINERS: Icanic Brands (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 3, 2022 ↗

January 03, 2022

GAINERS: BioHarvest Sciences (OTC:

Via Benzinga

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...

Via Benzinga

Marijuana & Psychedelic Compounds-Based Drug Stocks Now Down -16% YTD ↗

December 17, 2021

A look at which index has done the best so far in December: the Marijuana Drug Stocks Index or the Psychedelic Compounds-Based Drug Stocks Index.

Via Talk Markets

Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November ↗

December 01, 2021

A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.

Via Talk Markets

Topics Cannabis

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 15, 2021

Gainers Biofrontera (NASDAQ:BFRA) stock r...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 02, 2021

Good morning, trader! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Tuesday.

Via InvestorPlace

24 Stocks Moving in Tuesday's Pre-Market Session ↗

November 02, 2021

Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) rose 119% to $3.43 in pre-market trading after declining 3% on Monday. The company, last month, swung to a loss...

Via Benzinga

September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances ↗

October 01, 2021

Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September ↗

September 20, 2021

Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

Topics Cannabis

Marijuana Drug Stocks: All You Need To Know Is Here! ↗

August 13, 2021

Eight clinical-stage companies researching the treatment of a wide variety of illnesses using marijuana of which 6 have market capitalizations in excess of $50M and less than $500M and 2 have market...

Via Talk Markets

Topics Cannabis

Recap: Corbus Pharmaceuticals Q2 Earnings ↗

August 12, 2021

Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) decreased 1.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 71...

Via Benzinga

Which Psychedelic Drug Stock Category Outperformed Last Week ↗

August 10, 2021

Which has performed best YTD, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Via Talk Markets

Topics Cannabis

Intec Pharma, GreenTree & MedMen Among Top Cannabis Stock Movers On July 29, 2021 ↗

July 29, 2021

GAINERS: Intec Pharma (NASDAQ:

Via Benzinga

Topics Cannabis

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com